Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WuXi NextCODE was a global leader in applying big-data genomics to enable precision medicine, rare disease diagnosis, population-scale health projects, and drug discovery. The company built one of the world’s largest human genome databases and provided end-to-end solutions from sequencing to analysis for hospitals, pharma companies, governments, and researchers worldwide. Its technology has been used for over 12K rare disease diagnoses and underpinned major national genomics initiatives such as the UK’s 100K Genomes Project. In June 2020 it restructured its operations outside China under the new name Genuity Science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WuXi NextCODE.